R Plasmati

Summary

Affiliation: Bellaria Hospital
Country: Italy

Publications

  1. ncbi Neuropathy in multiple myeloma treated with thalidomide: a prospective study
    R Plasmati
    Dipartimento di Neuroscienze, Unita Operativa di Neurologia, Ospedale Bellaria, Bologna, Italy
    Neurology 69:573-81. 2007
  2. ncbi Chronic cerebro-spinal venous insufficiency: report of transcranial magnetic stimulation follow-up study in a patient with multiple sclerosis
    R Plasmati
    Department of Neurology, Bellaria Hospital, Bologna, Italy2 Vascular Diseases Centre, University of Ferrara, Italy
    Int Angiol 29:189-92. 2010
  3. ncbi Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation
    F Salvi
    Department of Neurological Sciences, University of Bologna at Bellaria Hospital, Bologna, Italy
    Neurol Sci 26:140-2. 2005
  4. ncbi The prevention of neural complications in the surgical treatment of scoliosis: the role of the neurophysiological intraoperative monitoring
    F Pastorelli
    Servizio di Neurofisiopatologia, Istituti Ortopedici Rizzoli, Bologna, Italy
    Eur Spine J 20:S105-14. 2011
  5. ncbi Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis
    M R Almeida
    Centro de Estudos de Paramiloidose, Instituto de Ciencias Biomedicas, Porto, Portugal
    Hum Mutat 1:211-5. 1992
  6. ncbi Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study
    G Cavaletti
    Dipartimento di Neuroscienze e Tecnologie Biomediche, Universita di Milano Bicocca, Monza, Italia
    Neurology 62:2291-3. 2004
  7. ncbi Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study
    L Guerrini
    Radiodiagnostic Section, Department of Clinical Physiopathology, University of Florence, Viale Morgagni 85, Florence, Italy
    Brain 127:1785-95. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Neuropathy in multiple myeloma treated with thalidomide: a prospective study
    R Plasmati
    Dipartimento di Neuroscienze, Unita Operativa di Neurologia, Ospedale Bellaria, Bologna, Italy
    Neurology 69:573-81. 2007
    ..Thalidomide is effective as a first-line therapy for the treatment of multiple myeloma (MM), but its use is limited by peripheral neurotoxicity...
  2. ncbi Chronic cerebro-spinal venous insufficiency: report of transcranial magnetic stimulation follow-up study in a patient with multiple sclerosis
    R Plasmati
    Department of Neurology, Bellaria Hospital, Bologna, Italy2 Vascular Diseases Centre, University of Ferrara, Italy
    Int Angiol 29:189-92. 2010
    ..The demonstration of a modification of the cerebrovenous function with both clinical manifestation and via TMS suggests that the hampered cerebral venous return may contribute to the clinical course of MS...
  3. ncbi Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation
    F Salvi
    Department of Neurological Sciences, University of Bologna at Bellaria Hospital, Bologna, Italy
    Neurol Sci 26:140-2. 2005
    ..Patients with Arg47 or other aggressive TTR amyloidoses should be considered high priority patients for orthotopic liver transplantation...
  4. ncbi The prevention of neural complications in the surgical treatment of scoliosis: the role of the neurophysiological intraoperative monitoring
    F Pastorelli
    Servizio di Neurofisiopatologia, Istituti Ortopedici Rizzoli, Bologna, Italy
    Eur Spine J 20:S105-14. 2011
    ..Early detection affords the surgical team an opportunity to perform rapid intervention to prevent injury progression or possibly to reverse impending neurologic sequelae...
  5. ncbi Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis
    M R Almeida
    Centro de Estudos de Paramiloidose, Instituto de Ciencias Biomedicas, Porto, Portugal
    Hum Mutat 1:211-5. 1992
    ..The basic variant has a glutamine residue replacing glutamate at position 89 (TTR Gln-89)...
  6. ncbi Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study
    G Cavaletti
    Dipartimento di Neuroscienze e Tecnologie Biomediche, Universita di Milano Bicocca, Monza, Italia
    Neurology 62:2291-3. 2004
    ..The risk of developing sensory neuropathy is around 10% below this threshold but increases with higher doses...
  7. ncbi Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study
    L Guerrini
    Radiodiagnostic Section, Department of Clinical Physiopathology, University of Florence, Viale Morgagni 85, Florence, Italy
    Brain 127:1785-95. 2004
    ....